高血圧性急性心不全:定義,疫学,病理生理学,および予後に関する批判的見解 - 叙述的なレビュー:ルーマニアの心臓病学会との共同セッション (第2部)
Oliviana Geavlete1,2, Sean P Collins3, Alexandre Mebazaa4
1Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', 258 Fundeni Street, 2 District, 022328, Bucharest, Romania. oliviana_m@yahoo.com.
Heart failure reviews
|September 2, 2025
まとめ
高血圧性急性心不全 (HT-AHF) は再評価されています. 他の急性心不全のタイプと重複する証拠があり,明確な結果や治療法がないため,その分類が疑問視されています.
科学分野:
- 心臓病科
- 臨床医学
- 心不全 の 研究
背景:
- 高血圧性急性心不全 (HT-AHF) は,急性心不全 (AHF) の認識された表型である.
- 急性肺詰まりと静脈動脈圧 (SBP) >140 mmHgで特徴付けられています.
- 新しい証拠により この分類の診断の正確性と臨床的有用性が疑問視されています
研究 の 目的:
- HT-AHFの概念を別々の臨床実体として批判的に評価する.
- HT-AHFの診断的重複,予後的影響,および治療的関連性を評価する.
- 高いSBPを持つAHFプレゼンテーションについて,より臨床的に有意義な記述子を提案する.
主な方法:
- HT-AHFに関する既存の文献と臨床的証拠のレビュー
- 診断基準,臨床的特徴,およびHT-AHFのアウトカム分析
- HT-AHFと他の急性無補償性心不全 (ADHF) のフェノタイプとの比較
主要な成果:
- HT-AHFはADHFと急性肺腫 (APO) のフェノタイプと重なり合っている.
- HT-AHFの入院死亡率は低い (0 - 2%) で,高いSBPと明らかに関連していない.
- 特定のHT-AHF治療で改善された結果を示す明確な管理戦略を支持する確固たる証拠はありません.
結論:
- HT-AHFを独立したカテゴリーとして分類する根拠は,その異質性と他のAHFタイプとの重複によって弱くなります.
- 予後的な区別と標的治療の欠如は,その独立した分類に異議を唱える.
- より柔軟で臨床的に適切なアプローチのために"プレゼンテーション時に高いSBPを持つAHF"を使用することを推奨します.
さらに関連する動画
関連する概念動画
Pathophysiology of Heart Failure
5.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
5.1K
Heart Failure I: Introduction
2.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2.0K
Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Heart Failure V: Medical Management
641
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
Hypertension II: Pathophysiology
1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K


